Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Major Customer Two Major Customer Two [Member] Represents the major customer of the entity. Award Timing Predetermined Award Timing Predetermined [Flag] 2026 (remaining nine months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Gross Carrying Value Intangible Assets, Gross (Excluding Goodwill) Indefinite-Lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Entity File Number Entity File Number Additional Paid-In Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Leases [Abstract] Intangible Asset, Acquired, Finite-Lived [Line Items] Intangible Asset, Acquired, Finite-Lived [Line Items] Recent Accounting Pronouncements Not Adopted New Accounting Pronouncements, Policy [Policy Text Block] Purchases of available-for-sale investments Payments to Acquire Short-Term Investments Accounts payable Increase (Decrease) in Accounts Payable SOFR Secured Overnight Financing Rate (SOFR) [Member] Common stock withheld for employee withholding tax liabilities on vested restricted stock units Common stock withheld for employee tax Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Probability of payment for remaining regulatory milestones Measurement Input, Expected Milestone Payment [Member] Measurement Input, Expected Milestone Payment [Member] Measurement Basis [Axis] Measurement Basis [Axis] Basic net income per common share (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Commercial paper Commercial Paper [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] REVENUE Revenue from Contract with Customer [Text Block] Discount rates Measurement Input, Discount Rate [Member] Schedule of Reconciliation of Significant Expense Categories Schedule of Segment Reporting Information, by Segment [Table Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Common stock issued under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Threshold percentage stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Vested restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of embedded leases Number Of Leases Number Of Leases Measurement Input Type [Domain] Measurement Input Type [Domain] Schedule of Short-Term and Noncurrent Available-for-Sale Investments Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Percentage of revenue from customers to total revenue Concentration risk Percentage of long lived assets Concentration Risk, Percentage Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Stock options Weighted average number of stock options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accrued excise tax Share Repurchase Program, Excise Tax Repayments for royalties Litigation Settlement, Amount Awarded from Other Party Balloon payment to be paid Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Amortization expense, seventh period Finite-Lived Intangible Asset, Expected Amortization, Year Seven Finite-Lived Intangible Asset, Expected Amortization, Year Seven Antidilutive Securities [Axis] Antidilutive Securities [Axis] Impairments Asset Impairment Charges Total stockholders’ equity Balance at beginning of period Balance at ending of period Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Total Share-Based Payment Arrangement, Expense Schedule of Fixed Assets Summarized by Major Category Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Segment Reporting, Asset Reconciling Item [Line Items] Segment Reporting, Asset Reconciling Item [Line Items] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Current assets: Assets, Current [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity EARNINGS PER SHARE Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Weighted average interest rate Line of Credit Facility, Interest Rate at Period End Number of Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Cover page. Cover [Abstract] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Maximum Maximum Maximum [Member] Bridge Loan Bridge Loan [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Intangible Assets, Net Finite-Lived Intangible Assets, Net LG Chem, Partnership Agreement LG Chem, Partnership Agreement [Member] LG Chem, Partnership Agreement Discount rate Debt Instrument, Discount Rate Debt Instrument, Discount Rate Schedule of Maturities of Operating Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Repayment of Term loan A facility Repayments of Secured Debt Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Treasury Shares Treasury Stock, Common [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Contingent Consideration Contingent Consideration [Member] Contingent Consideration [Member] Total operating lease liabilities Operating Lease, Liability Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Purchase of capped calls Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Before Tax Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Before Tax Broker fees Share Repurchase Program, Broker Fees Share Repurchase Program, Broker Fees Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Term three Debt Conversion Terms Three [Member] Debt Conversion Terms Three Income before income taxes Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Other liabilities Other Liabilities, Noncurrent Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Investments Without Readily Determinable Fair Value Roll Forward [Abstract] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] RSU and PSU Restricted Stock Units and Performance Stock Units [Member] Restricted Stock Units and Performance Stock Units Goodwill impairment Goodwill, Impairment Loss Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Key employee holdback recognition year three Business Combination, Liabilities Arising from Contingencies, Percent, Year Three Business Combination, Liabilities Arising from Contingencies, Percent, Year Three Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Measurement Input Type [Axis] Measurement Input Type [Axis] Name Measure Name Schedule of Income Before Income Taxes and Income Tax Expense Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Letter of Credit Letter of Credit [Member] Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Schedule of Recognized Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Term Loan Secured Debt [Member] Lease liabilities Operating Lease, Liability, Current Schedule of Change in Contingent Consideration Recorded at Fair Value using Level 3 Measurements Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Terms one Debt Conversion Terms One [Member] Debt Conversion Terms One Wells Fargo Bank Wells Fargo Bank, National Association, Credit Agreement [Member] Wells Fargo Bank, National Association, Credit Agreement Deferred tax liabilities Deferred Income Tax Liabilities, Net Document Fiscal Period Focus Document Fiscal Period Focus Unsecured Debt Unsecured Debt [Member] Award Timing Method Award Timing Method [Text Block] Litigation Case [Domain] Litigation Case [Domain] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) ESPP purchasing period Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period Office furniture and equipment Furniture and Fixtures [Member] Award Type [Axis] Award Type [Axis] Unrealized Foreign Currency Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Total Total debt, net of deferred financing costs Long-Term Debt Legal Entity [Axis] Legal Entity [Axis] Total assets Assets Investing activities: Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Amortization expense, first period Finite-Lived Intangible Asset, Expected Amortization, Year One Trading Symbol Trading Symbol 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Number of major customers Number of Major Customers Represents the number of major customers of the reporting entity. Percentage of last reported sale price of common stock Debt Instrument, Convertible, Threshold Percentage Of Stock Trading Price Debt Instrument, Convertible, Threshold Percentage Of Stock Trading Price Geographical [Domain] Geographical [Domain] Entity Address, City or Town Entity Address, City or Town Receivable Type [Axis] Receivable Type [Axis] Aggregate principal amount Debt Instrument, Covenant, Incremental Debt, Maximum Debt Instrument, Covenant, Incremental Debt, Maximum Weighted-Average Useful Lives Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Concentration Risk Type [Axis] Concentration Risk Type [Axis] INVENTORIES Inventory Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Restricted stock units RSUs Weighted average number of RSUs Restricted Stock Units (RSUs) [Member] Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Schedule of Intangible Assets Business Combination, Intangible Asset, Acquired, Finite-Lived [Table Text Block] Required principal repayment on conversion Debt Instrument, Repurchased In Conversion Face Amount Debt Instrument, Repurchased In Conversion Face Amount Amortization expense, fourth period Finite-Lived Intangible Asset, Expected Amortization, Year Four Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Right-of-use assets recorded in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Fair Value Measurements Debt Securities, Available-for-Sale [Line Items] Total operating lease expense, net Lease, Cost [Abstract] Outstanding beginning of period (in shares) Outstanding end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Repayment of Revolving Credit Facility Repayments of Lines of Credit Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Deferred financing costs Debt Issuance Costs, Net Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Gross Carrying Value Indefinite-Lived Intangible Assets (Excluding Goodwill) Business Combination [Domain] Business Combination [Domain] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Number of offering periods for ESPP Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods Investment Categorization [Axis] Investment Categorization [Axis] Investment Categorization Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Four Lessee, Operating Lease, Liability, to be Paid, after Year Four Brendan Teehan [Member] Brendan Teehan Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Number of notices are filed Loss Contingency, Pending Claims, Number Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Interest income Investment Income, Interest Accrued income taxes Accrued Income Taxes, Current U.S UNITED STATES Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net income per common share: Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Premium Derivative, Premium Percentage Derivative, Premium Percentage Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Other net gains Provision for Other Losses Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Number of Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Income tax expense Income tax expense Income tax expense Income Tax Expense (Benefit) Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Option extended term Contractual Obligation, Minimum Monthly Commission, Duration Contractual Obligation, Minimum Monthly Commission, Duration Net leverage ratio Debt Instrument, Basis Spread on Variable Rate Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Inducement Plan 2014 Inducement Plan 2014 [Member] Inducement Plan 2014 Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Intangible assets, net Intangible Assets, Net Intangible Assets, Net (Excluding Goodwill) Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Adjusted research and development Research And Development, Adjusted Research And Development, Adjusted Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Customer concentration Customer concentration Customer Concentration Risk [Member] Contractual interest expense Interest Expense, Debt, Excluding Amortization Total Property, Plant and Equipment, Gross Long-lived Assets Property, Plant and Equipment [Member] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Payment term Contingent Consideration, Payment Term Contingent Consideration, Payment Term Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Supplemental cash flow information related to operating leases Cash Flow, Operating Activities, Lessee [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Proceeds from exercises of stock options Proceeds from Stock Options Exercised City Area Code City Area Code Acquisition of GQ Bio Therapeutics GmbH (net of cash acquired) Payments to Acquire Businesses, Net of Cash Acquired Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Repurchase price percent Debt Instrument, Redemption Price, Percentage Accrued expenses Total Accrued Liabilities, Current Unvested at beginning of period (in shares) Unvested at end of period in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Proceeds from Revolving Credit Facility Proceeds from Long-Term Lines of Credit Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Largest wholesaler Largest Customer [Member] Represents the largest customer of the entity. Interest receivable Interest Receivable Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Schedule of Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Selling, general and administrative Selling, General and Administrative Expenses [Member] Total Lease, Cost Cost of goods sold Cost of Sales [Member] Goodwill Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Schedule of Operating Lease Expense and Other Operating Lease Information Lease, Cost [Table Text Block] Sales of available-for-sale investments Proceeds from Sale of Short-Term Investments PEO Total Compensation Amount PEO Total Compensation Amount Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Depreciation expense Depreciation Concentration of products (in products) Concentration Risk, Number Of Products Concentration Risk, Number Of Products Amortization expense, remainder of fiscal year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Convertible notes receivable Notes Receivable, Fair Value Disclosure 0.750% Convertible senior notes due August 2025 Convertible Senior Notes Due 2025 [Member] Convertible Senior Notes Due 2025 Accrued selling, general and administrative expenses Accrued Selling, General, And Administrative Expenses Amount of liabilities incurred and payable to vendors for goods and services related to selling, general, and administrative activities. Equity Components [Axis] Equity Components [Axis] Outside of the U.S. Non-US [Member] FIXED ASSETS Property, Plant and Equipment [Line Items] Convertible Debt Convertible Debt [Member] Sublease income Sublease Income Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of paragraph certification Number Of Paragraph IV Certifications Number Of Paragraph IV Certifications Concentration Risk [Table] Concentration Risk [Table] Net product sales Total net product sales Product [Member] Number of reportable segments Number of Reportable Segments Key assumptions Business Combination, Contingent Consideration, Liability, Measurement Input Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Convertible Notes Receivable Convertible Notes Receivable [Member] Convertible Notes Receivable Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Cost Debt Securities, Available-for-Sale, Amortized Cost Other Performance Measure, Amount Other Performance Measure, Amount Expect to receive partial summary judgment Litigation Settlement, Amount Expected To Be Awarded from Other Party Litigation Settlement, Amount Expected To Be Awarded from Other Party Weighted Average Exercise Price (Per Share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] EBITDA (in percent) Debt Instrument, Covenant, Incremental Debt, Maximum Percent Debt Instrument, Covenant, Incremental Debt, Maximum Percent Total current liabilities Liabilities, Current Capitalized interest (Note 5) Interest Costs Capitalized Adjustment Derivative Instrument [Axis] Derivative Instrument [Axis] Individual: Individual [Axis] Development and Global Regulatory Approval Milestone Payments Development and Global Regulatory Approval Milestone Payments [Member] Development and Global Regulatory Approval Milestone Payments Research and development Research and Development Expense [Member] Entity [Domain] Entity [Domain] Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Right-of-use assets, net Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Effective tax rate (in percent) Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Fixed lease costs Operating Lease, Cost Operating activities: Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Plan Name [Domain] Plan Name [Domain] Carrying Value Reported Value Measurement [Member] Acquisition-related expenses Business Combination, Acquisition-Related Cost, Expense Exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Adjusted selling and marketing Selling And Marketing, Adjusted Selling And Marketing, Adjusted SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Periodic payment, principal Debt Instrument, Periodic Payment, Principal Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Ownership [Domain] Ownership [Domain] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Acquisition-related contingent consideration Business Combination, Contingent Consideration, Liability Weighted Average Weighted Average [Member] Amortization of acquired intangible assets Amortization of Intangible Assets Selling, general and administrative Selling, General and Administrative Expense GQ Bio Therapeutics GmbH GQ Bio Therapeutics GmbH [Member] GQ Bio Therapeutics GmbH Deferred tax assets Deferred Income Tax Assets, Net Schedule of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Depreciation of fixed assets and amortization of intangible assets Depreciation, Depletion and Amortization Initial conversion rate Debt Instrument, Convertible, Conversion Ratio Accrued interest Interest Payable, Current Name of Major Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Financial Assets: Receivables, Fair Value Disclosure [Abstract] Initial conversion price of notes into common stock (in dollars per share) Debt Instrument, Convertible, Conversion Price Asset retirement obligation Asset Retirement Obligation Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Fair Value Measurements Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Reportable Segment Reportable Segment [Member] Reportable Segment Revolving Credit Facility Revolving Credit Facility [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Arrangement Duration Trading Arrangement Duration FINANCIAL INSTRUMENTS Financial Instruments Disclosure [Text Block] Schedule of Other Operating (Gains) Expenses, Net Schedule of Other Operating Cost and Expense, by Component [Table Text Block] Segments [Axis] Segments [Axis] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Work-in-process Inventory, Work in Process, Net of Reserves Product returns and wholesaler service fees Product Warranty Accrual, Current Exercise Price Award Exercise Price Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Share price (in dollars per share) Closing sale price (in dollars per share) Share Price ASSETS Assets [Abstract] Long-term debt, net Long-Term Debt, Excluding Current Maturities Credit Facility [Axis] Credit Facility [Axis] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Amortization expense, third period Finite-Lived Intangible Asset, Expected Amortization, Year Three Achievement of Milestone [Axis] Achievement of Milestone [Axis] Information by categories of milestones achieved. Achievement of commercial milestones (up to) Collaborative Arrangement, Milestone Payments to be Received, Maximum Represents the amount of milestone payments the Company is entitled to receive based on the terms of the agreement. Volumes distributed in US market in duration period Litigation Settlement, Volume-Limited, Increase Period Litigation Settlement, Volume-Limited, Increase Period Debt Instrument [Axis] Debt Instrument [Axis] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value (Loss) gain on early extinguishment of debt Gain (Loss) on Extinguishment of Debt Credit Facility [Domain] Credit Facility [Domain] Gross Carrying Value Finite-Lived Intangible Assets, Gross Stockholders’ equity: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Purchase of treasury stock, inclusive of excise tax Purchase of treasury stock, inclusive of excise tax Treasury Stock, Value, Acquired, Cost Method Research and development Research and Development Expense Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Amount of allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Capped Call Capped Call [Member] Capped Call Stated rate Debt Instrument, Interest Rate, Stated Percentage Common stock withheld for employee withholding tax liabilities on vested restricted stock units (in shares) Withheld shares in common stock (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Lease liabilities Operating Lease, Liability, Noncurrent Ownership [Axis] Ownership [Axis] Fair Value as of Grant Date Award Grant Date Fair Value Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Income tax payable Accrued Income Taxes Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Dilutive effect of share based compensation arrangements (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Total operating expenses Costs and Expenses Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Document Quarterly Report Document Quarterly Report Deferred taxes Deferred Income Taxes and Tax Credits Schedule of Key Assumptions used in the Valuation of Contingent Consideration Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Basis of Presentation and Principles of Consolidation Basis of Presentation and Principles of Consolidation [Policy Text Block] Disclosure of accounting policy for basis of presentation and principles of consolidation. Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Equity investments Equity Securities without Readily Determinable Fair Value, Amount Number of operating segments Number of Operating Segments 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Net accretion of discount on available-for-sale investments Accretion (Amortization) of Discounts and Premiums, Investments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Germany GERMANY Payment of debt Repayments of Convertible Debt Schedule of Composition of the Company's Debt and Financing Obligations Schedule of Debt [Table Text Block] Machinery and equipment Machinery and Equipment [Member] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Accounts Receivable Accounts Receivable [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Total Interest Expense, Debt Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Debt Instrument, Convertible Terms Of Conversion [Axis] Debt Instrument, Convertible Terms Of Conversion [Axis] Debt Instrument, Convertible Terms Of Conversion Schedule of Carrying Amount and Fair Value of the Long-Term Debt Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Adjusted general and administrative Selling, General And Administrative Adjusted Selling, General And Administrative Adjusted Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Name Trading Arrangement, Individual Name Equity Award [Domain] Award Type [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] MyoScience Milestone Litigation MyoScience Milestone Litigation [Member] MyoScience Milestone Litigation Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] 2.125% Convertible senior notes due May 2029 Convertible Senior Notes Due 2029 [Member] Convertible Senior Notes Due 2029 Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] OTHER OPERATING (GAINS) EXPENSES, NET Other Operating Income and Expense [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Aggregate principal amount Debt Instrument, Face Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Contingent consideration Contingent Consideration, Noncurrent Contingent Consideration, Noncurrent Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Fair Value Measurements Using Estimate of Fair Value Measurement [Member] Amortization expense, sixth period Finite-Lived Intangible Asset, Expected Amortization, Year Six Finite-Lived Intangible Asset, Expected Amortization, Year Six MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Income before income taxes: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Unvested at beginning of period (in dollars per share) Unvested at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Debt Instrument, Convertible Terms Of Conversion [Domain] Debt Instrument, Convertible Terms Of Conversion [Domain] Debt Instrument, Convertible Terms Of Conversion [Domain] Bupivacaine liposome injectable suspension Bupivacaine Liposome Injectable Suspension [Member] Bupivacaine Liposome Injectable Suspension Changes in contingent consideration Contingent consideration gain Contingent consideration gains Changes in the fair value of contingent consideration Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Weighted average ESPP share options Employee stock purchase plan share options Employee Stock [Member] Revenues: Revenues [Abstract] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Tax benefit OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Acquired IPR&D In Process Research and Development [Member] Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Convertible Note Receivable Convertible Note Receivable [Member] Convertible Note Receivable Johnson & Johnson MedTech Johnson & Johnson MedTech [Member] Johnson & Johnson MedTech Financial Instruments [Domain] Financial Instruments [Domain] EXPAREL EXPAREL [Member] EXPAREL/bupivacaine liposome injectable suspension [Member] Litigation Case [Axis] Litigation Case [Axis] Liability Class [Axis] Liability Class [Axis] Segments [Domain] Segments [Domain] Purchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Performance share units Performance Share Units Performance Shares [Member] Accrued production costs Accrued Production Cost Accrued Production Cost Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Royalty revenue Royalty [Member] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Inventories, net Increase (Decrease) in Inventories Inventories, net Total Inventory, Net Developed technologies Developed Technology Rights [Member] Amortization of debt issuance costs and debt discount Amortization of Debt Issuance Costs and Discounts Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Lauren Riker [Member] Lauren Riker Minimum Minimum [Member] Investments and other assets Equity Method Investments and Other Assets Equity Method Investments and Other Assets Net Unrealized Gain (Loss) From Available-For-Sale Investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Company Selected Measure Name Company Selected Measure Name Investment Categorization [Domain] Investment Categorization [Domain] Investment Categorization [Domain] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Schedule of Available-for-sale Securities [Table] Schedule of Short-Term and Noncurrent Available-For-Sale Investments [Table] Schedule of Short-Term and Noncurrent Available-For-Sale Investments 2025 Notes Senior Notes [Member] DEBT Debt Disclosure [Text Block] Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025 Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount GeneQuine GeneQuine [Member] GeneQuine Accounts payable Accounts Payable, Current Cash paid for operating lease liabilities, net of lease incentives Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Impairments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments Mutual termination rights term Contractual Obligation, Mutual Termination Rights Term Contractual Obligation, Mutual Termination Rights Term Number of generic drug manufacturers Number Of Generic Drug Manufacturers Number Of Generic Drug Manufacturers All Executive Categories All Executive Categories [Member] Other Other Nonrecurring (Income) Expense Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Finished goods Inventory, Finished Goods, Net of Reserves Common stock, par value $0.001; 250,000,000 shares authorized; 48,328,201 shares issued and 39,309,610 shares outstanding at March 31, 2026 and 47,890,777 shares issued and 41,116,739 shares outstanding at December 31, 2025 Common Stock, Value, Issued Adjusted cost of goods sold Cost Of Goods Sold, Adjusted Cost Of Goods Sold, Adjusted Short-term available-for-sale investments Short-Term Investments COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Diluted (in shares) Weighted average number of shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies (Note 16) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Reconciliation of Assets from Segment to Consolidated [Table] Reconciliation of Assets from Segment to Consolidated [Table] Term loan A facility maturing March 2028 Term Loan A Facility Due March 2028 [Member] Term Loan A Facility Due March 2028 Business Combination [Axis] Business Combination [Axis] Entity Small Business Entity Small Business Percentage of voting interests acquired Business Combination, Voting Equity Interest Acquired, Percentage Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Current: Short-Term Investments [Member] Schedule of Percentage of Revenue Comprised of Three Largest Customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Underlying Securities Award Underlying Securities Amount Concentration Risk [Line Items] Concentration of Major Customers Concentration Risk [Line Items] Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount INCOME TAXES Income Tax Disclosure [Text Block] Third largest wholesaler Third Largest Customer [Member] Represents the third largest customer of the entity. Net proceeds from loan Proceeds from Lines of Credit Key employee holdback recognition year two Business Combination, Liabilities Arising from Contingencies, Percent, Year Two Business Combination, Liabilities Arising from Contingencies, Percent, Year Two U.K UNITED KINGDOM Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total Three Largest Customers [Member] Three Largest Customers Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Convertible senior notes Debt Instrument, Fair Value Disclosure Range of milestone payment Revenue from Contract with Customer, Milestone Payments, Maximum Revenue from Contract with Customer, Milestone Payments, Maximum Scenario [Axis] Scenario [Axis] Amortization of debt discount Amortization of Debt Discount (Premium) Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] NET INCOME PER COMMON SHARE Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Legal settlement Litigation Settlement, Loss Variable lease costs Variable Lease, Cost Total revenues Total net product sales Revenue from Contract with Customer, Excluding Assessed Tax Key employee holdback recognition year one Business Combination, Liabilities Arising from Contingencies, Percent, Year One Business Combination, Liabilities Arising from Contingencies, Percent, Year One Share based compensation service period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period All Individuals All Individuals [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Purchases of fixed assets Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Convertible note receivable Payments to Acquire Notes Receivable Additional interest payment Litigation Settlement Interest Aggregate purchase Share Repurchase Program, Authorized, Amount Number of employee compensation Business Combination, Contingency Recognized at Acquisition Date, Employee Compensation Liability Assumed, Number Of Employees Business Combination, Contingency Recognized at Acquisition Date, Employee Compensation Liability Assumed, Number Of Employees Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Purchase price of common stock, ESPP (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Foreign currency adjustments Goodwill, Foreign Currency Translation, Gain (Loss) Payment of employee withholding taxes on restricted stock unit vests Payment, Tax Withholding, Share-Based Payment Arrangement Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Gross deferred tax assets, deduction year two Deferred Tax Assets, Tax Credit Carryforwards, Research, Deduction Year Two Deferred Tax Assets, Tax Credit Carryforwards, Research, Deduction Year Two Total other comprehensive (loss) income Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current liabilities: Liabilities, Current [Abstract] Gross deferred tax assets Deferred Tax Assets, Tax Credit Carryforwards, Research Geographical [Axis] Geographical [Axis] Accrued research and development expenses Accrued Research And Development Expenses Amount of liabilities incurred and payable to vendors for goods and services related to research and development activities. Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Agreement period of volumes distributed in market Litigation Settlement, Volume-Limited, Maximum Percentage, Period Litigation Settlement, Volume-Limited, Maximum Percentage, Period Achievement of Milestone [Domain] Achievement of Milestone [Domain] Different categories of achievement of milestones. Level 1 Fair Value, Inputs, Level 1 [Member] Outstanding Long-Term Line of Credit Increasing modestly period Litigation Settlement, Volume-Limited, Number Of Moderate Increase Periods Litigation Settlement, Volume-Limited, Number Of Moderate Increase Periods Stock-based compensation from: Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accrued expenses Increase (Decrease) in Accrued Liabilities Diluted net income per common share (in dollars per share) Earnings Per Share, Diluted Forecast Forecast [Member] Gross deferred tax assets, deduction year one Deferred Tax Assets, Tax Credit Carryforwards, Research, Deduction Year One Deferred Tax Assets, Tax Credit Carryforwards, Research, Deduction Year One Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Flexion Acquisition Flexion Acquisition [Member] Flexion Acquisition AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Excise tax on share repurchases included in accrued liabilities Share Repurchase Program, Excise Tax, Payable Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Treasury stock (in shares) Treasury Shares, Beginning balance (in shares) Treasury Shares, Ending balance (in shares) Treasury Stock, Common, Shares Net income per common share: Earnings Per Share [Abstract] Total other (expense) income, net Total other (expense) income, net Nonoperating Income (Expense) ZILRETTA ZILRETTA [Member] ZILRETTA Schedule of Potential Dilutive Effect of the Securities Excluded from the Calculation of Diluted Income Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Outstanding principal balance Debt Instrument, Repaid, Principal Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Net cash paid for income taxes Income Taxes Paid, Net Purchase of treasury stock, inclusive of excise tax (in shares) Purchase of treasury stock, inclusive of excise tax (in shares) Treasury Stock, Shares, Acquired Corporate bonds Corporate Bond Securities [Member] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Amortization expense, second period Finite-Lived Intangible Asset, Expected Amortization, Year Two Award Timing Disclosures [Line Items] Baylor College of Medicine (Baylor) Baylor College of Medicine (Baylor) [Member] Baylor College of Medicine (Baylor) Schedule of Components of Inventories Schedule of Inventory, Current [Table Text Block] 2.125% convertible senior notes due May 2029 Long-Term Debt, Gross Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Market price of principal amount of notes Debt Instrument, Market Price Debt market price, per $1,000 principal amount. Compensation and benefits Employee-related Liabilities, Current FIXED ASSETS Property, Plant and Equipment Disclosure [Text Block] Achievement of Development and Regulatory Milestones Achievement of Development and Regulatory Milestones [Member] Achievement of Development and Regulatory Milestones Total future lease payments Lessee, Operating Lease, Liability, to be Paid Net unrealized loss on investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax STOCKHOLDERS' EQUITY Equity [Text Block] Effective interest rate on total debt (in percent) Debt Instrument, Interest Rate During Period Payment terms Accounts Receivable, Payment Terms Accounts Receivable, Payment Terms Net income Net income Net income Net income Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Settlement period - convertible debt conversion request Settlement Period - Convertible Debt Conversion Request The number of trading days in a settlement period for convertible debt conversion requests. Key employee holdback agreement Business Combination, Contingency Recognized at Acquisition Date, Liability Assumed, Fair Value Construction in progress Construction in Progress [Member] Other liabilities Increase (Decrease) in Other Operating Liabilities Other accrued operating expenses Other Accrued Liabilities, Current Amortization expense, fifth period Finite-Lived Intangible Asset, Expected Amortization, Year Five Share based compensation vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Fixed assets, net Fixed assets, net Property, Plant and Equipment, Net Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Geographic Concentration Risk Geographic Concentration Risk [Member] Purchase of treasury stock, inclusive of broker fees Payments for Repurchase of Common Stock Adoption Date Trading Arrangement Adoption Date Base Rate Base Rate [Member] iovera° iovera° [Member] iovera° [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable, net Increase (Decrease) in Accounts Receivable Scheduled trading day Debt Instrument, Convertible, Redemption, Trading Days From Maturity Debt Instrument, Convertible, Redemption, Trading Days From Maturity Entity Current Reporting Status Entity Current Reporting Status Major Customers [Axis] Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Financing activities: Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Customer relationships Customer Relationships [Member] Income from operations Operating Income (Loss) Line of Credit Line of Credit [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Financial Instrument [Axis] Financial Instrument [Axis] Purchase of capped calls, tax Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Tax Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Tax Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Repayments of debt Repayments of Debt STOCK PLANS Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block] Other operating (gains) expenses, net Total other operating (gains) expenses, net Other Operating Income (Expense), Net GQ Bio Acquisition GQ Bio Acquisition [Member] GQ Bio Acquisition Current Fiscal Year End Date Current Fiscal Year End Date Expected term of options Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Other Other Cost of Operating Revenue Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Second largest wholesaler Second Largest Customer [Member] Represents the second largest customer of the entity. Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Initiation of a Phase 2 Clinical Trial Initiation of a Phase 2 Clinical Trial [Member] Initiation of a Phase 2 Clinical Trial Payables and Accruals [Abstract] Weighted Average Grant Date Fair Value (Per Share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Number of shares remain available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Other, net Other Nonoperating Income (Expense) Statement [Table] Statement [Table] Adjustments to reconcile net income to net cash provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Revenue Revenue Benchmark [Member] Upfront payment Contract with Customer, Liability Variable Rate [Domain] Variable Rate [Domain] DESCRIPTION OF BUSINESS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Research Development Foundation Research Development Foundation [Member] Research Development Foundation Antidilutive effects of including these potential shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Investments without Readily Determinable Fair Value Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Weighted average common shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Amendment Flag Amendment Flag Stock incentive plan, awards reserved for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Major Customer Three Major Customer Three [Member] Represents the major customer of the entity. Treasury stock, at cost, inclusive of excise tax and broker fees, 9,018,591 and 6,774,038 shares at March 31, 2026 and December 31, 2025, respectively Treasury Stock, Common, Value Equity Investment And Convertible Note Receivable Equity Investment And Convertible Note Receivable [Member] Equity Investment And Convertible Note Receivable Borrowings Debt Issuance Costs, Line of Credit Arrangements, Net LEASES Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Receivable [Domain] Receivable [Domain] Raw materials Inventory, Raw Materials, Net of Reserves Weighted average discount rate (in percent) Operating Lease, Weighted Average Discount Rate, Percent Schedule of Stock Option Activity and RSU and PSU Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Financial Liabilities: Financial Liabilities Fair Value Disclosure [Abstract] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Vested restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Basic (in shares) Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Remaining available for future purchases Share Repurchase Program, Remaining Authorized, Amount Schedule of Computation of Basic and Diluted Net Income Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Segment Reporting [Abstract] Cost of goods sold (exclusive of amortization of acquired intangible assets) Cost of Revenue Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Amortization of debt issuance costs Amortization of Debt Issuance Costs Other income (expense): Nonoperating Income (Expense) [Abstract] Entity Tax Identification Number Entity Tax Identification Number Scenario, Unspecified [Domain] Scenario [Domain] Number of customers Concentration Risk, Number of Customers Concentration Risk, Number of Customers Debt instrument, unamortized discount Debt Instrument, Unamortized Discount Outstanding beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Interest payment Interest Paid, Including Capitalized Interest, Operating and Investing Activities Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Schedule of Total Interest Expense Recognized Related to the Notes Schedule of Interest Expense [Table Text Block] Tabular disclosure of the amount of interest rate expenses related to convertible notes. Stock Incentive Plans Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Income tax receivable Income Taxes Receivable, Current Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Payment received Proceeds from Legal Settlements Convertible debt, premium on common stock Debt Instrument, Conversion Obligation Premium on Common Stock Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument. Settled investments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Foreign currency adjustments Fair value adjustments and accretion Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Major Customer One Major Customer One [Member] Represents the major customer of the entity. Equity Investments Equity Securities [Member] Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Product Product Concentration Risk [Member] Fixed assets included in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid Commitment amount Line of Credit Facility, Maximum Borrowing Capacity Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Repurchased aggregate principal Debt Instrument, Repurchased Face Amount Indefinite-Lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Operating expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Flexion Flexion Therapeutics, Inc. [Member] Flexion Therapeutics, Inc. Realized gain of prior investments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Key employee holdback agreement payment period Business Combination, Liabilities Arising from Contingencies, Period Of Recognized Business Combination, Liabilities Arising from Contingencies, Period Of Recognized Statement [Line Items] Statement [Line Items] Statement [Line Items] Cap price (in USD per share) Derivative, Capped Call Price Derivative, Capped Call Price Variable Rate [Axis] Variable Rate [Axis] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Computer equipment and software Computer Equipment and Software [Member] Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems. Cash and cash equivalents Cash and Cash Equivalent Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Counterparty Name [Axis] Counterparty Name [Axis] Additional shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Threshold trading days Debt Instrument, Convertible, Threshold Trading Days Common Shares Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Fair Value Debt Securities, Available-for-Sale Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Term two Debt Conversion Terms Two [Member] Debt Conversion Terms Two Non-NEOs Non-NEOs [Member] Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation